Which hormones promote breast cancer in postmenopause: Estrogens, progestins, insulin and/or adipocytokines?

被引：0
|
作者：
Jamin, C. [1 ]
机构：
[1] AFACS, F-75008 Paris, France
来源：
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2010年 / 38卷 / 01期
关键词：
DIETARY GLYCEMIC INDEX; PHYSICAL-ACTIVITY; PLUS PROGESTIN; FATTY-ACIDS; RISK; WOMEN; RESISTANCE; MORTALITY; SURVIVAL; THERAPY;
D O I：
10.1016/j.gyobfe.2009.11.004
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Emily J. Gallagher
    Zara Zelenko
    Aviva Tobin-Hess
    Ulrich Werner
    Norbert Tennagels
    Derek LeRoith
    Diabetologia, 2016, 59 : 2018 - 2025
  • [42] Inhibition of PI3K induces paracrine factors, which promote growth and survival of human breast cancer cells
    Young, Christian D.
    Koch, James P.
    Cook, Rebecca S.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2015, 75
  • [43] Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Emily J. Gallagher
    Zara Zelenko
    Aviva Tobin-Hess
    Ulrich Werner
    Norbert Tennagels
    Derek LeRoith
    Diabetologia, 2017, 60 : 758 - 759
  • [44] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS BY T-47D HUMAN BREAST-CANCER CELLS - REGULATION BY PROGESTINS AND ANTIESTROGENS
    COUTTS, A
    MURPHY, LJ
    MURPHY, LC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (02) : 153 - 164
  • [45] GROWTH-INHIBITION AND INCREASE OF INSULIN-RECEPTORS IN ANTIESTROGEN-RESISTANT T47DCO HUMAN-BREAST CANCER-CELLS BY PROGESTINS - IMPLICATIONS FOR ENDOCRINE THERAPIES
    HORWITZ, KB
    FREIDENBERG, GR
    CANCER RESEARCH, 1985, 45 (01) : 167 - 173
  • [46] Interleukin 2 and interleukin 10 function synergistically to promote CD8+ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer
    Li, Xiaogang
    Lu, Ping
    Li, Bo
    Zhang, Wanfu
    Yang, Rong
    Chu, Yan
    Luo, Kaiyuan
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 87 : 1 - 7
  • [47] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes (vol 59, pg 2018, 2016)
    Gallagher, Emily J.
    Zelenko, Zara
    Tobin-Hess, Aviva
    Werner, Ulrich
    Tennagels, Norbert
    LeRoith, Derek
    DIABETOLOGIA, 2017, 60 (04) : 758 - 759
  • [48] Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects
    Dupont, J
    Le Roith, D
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2001, 54 (03): : 149 - 154
  • [49] PROGESTINS INDUCE DOWN-REGULATION OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) RECEPTORS IN HUMAN BREAST-CANCER CELLS - POTENTIAL AUTOCRINE ROLE OF IGF-II
    PAPA, V
    HARTMANN, KKP
    ROSENTHAL, SM
    MADDUX, BA
    SIITERI, PK
    GOLDFINE, ID
    MOLECULAR ENDOCRINOLOGY, 1991, 5 (05) : 709 - 717
  • [50] Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines
    Ashok K. Chakraborty
    Allison Welsh
    Michael P. DiGiovanna
    Breast Cancer Research and Treatment, 2010, 120 : 327 - 335
12345